Study setting {9}
psychiatric, OUD, SUD
DISORDER
This trial is conducted within a single, urban substance use disorder (SUD) treatment center affiliated with a university and university health system. The treatment center includes a licensed outpatient opioid treatment program and a residential treatment program, both of which serve pregnant and/or parenting women exclusively. At both outpatient and residential levels of care, all patients receive comprehensive wraparound services, including methadone and buprenorphine as medications for OUD, psychiatric medications and psychotherapy, cognitive behavioral therapy and mindfulness-based therapy for substance use disorder in individual, family, and group formats, case management, medical care coordination, peer recovery support, mindfulness-based parenting psychoeducation, and various other services especially needed by the population of pregnant and/or parenting women with SUDs. At the residential level of care, women live with their children at the facility and receive the majority of programming at the facility for an average of 6 months. Upon completion of residential treatment, the majority of patients continue their SUD treatment at the outpatient facility. Patients are welcome to participate in the outpatient program for as long as they desire, and the average length of outpatient treatment is 3–4 years. Across both programs, the treatment center serves approximately 250 women each year.